Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDProKidney Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.16 | -$0.13 | -$0.14 |
| Q2 2026 | 4 | -$0.16 | -$0.12 | -$0.14 |
| Q3 2026 | 4 | -$0.19 | -$0.16 | -$0.17 |
| Q4 2026 | 2 | -$0.17 | -$0.17 | -$0.17 |
| Q1 2027 | 2 | -$0.16 | -$0.16 | -$0.16 |
| Q2 2027 | 1 | -$0.12 | -$0.12 | -$0.12 |
| Q3 2027 | 1 | -$0.11 | -$0.11 | -$0.11 |
| Q4 2027 | 2 | -$0.12 | -$0.12 | -$0.12 |
ProKidney Corp Earnings Date And Information
ProKidney Corp last posted its earnings results on Friday, May 15th, 2026. The company reported $-0.14 earnings per share for the quarter, missing analysts' consensus estimates of $-0.13 by $0.01. The company had revenue of 226.00 K for the quarter and had revenue of 893.00 K for the year. ProKidney Corp has generated $-1 earnings per share over the last year ($-0.52 diluted earnings per share) and currently has a price-to-earnings ratio of -3.31. ProKidney Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
ProKidney Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/15/2026 | Q1 2026 | -$0.13 | -$0.16 | -0.03 | $100.25 K | $226.00 K |
| 03/18/2026 | Q4 2025 | -$0.16 | -$0.14 | 0.02 | $600 | $225.00 K |
| 11/10/2025 | Q3 2025 | -$0.12 | -$0.12 | 0 | $59.00 K | $217.00 K |
| 08/12/2025 | Q2 2025 | -$0.14 | -$0.13 | 0.01 | N/A | $221.00 K |
| 05/12/2025 | Q1 2025 | -$0.16 | -$0.13 | 0.03 | N/A | $230.00 K |
| 03/17/2025 | Q4 2024 | -$0.14 | -$0.17 | -0.03 | N/A | $76.00 K |
| 11/12/2024 | Q3 2024 | -$0.14 | -$0.14 | 0 | N/A | $0 |
| 08/09/2024 | Q2 2024 | -$0.17 | -$0.16 | 0.01 | N/A | $0 |
| 05/10/2024 | Q1 2024 | -$0.25 | -$0.16 | 0.09 | N/A | $0 |
| 03/21/2024 | Q4 2023 | N/A | -$0.10 | N/A | N/A | $0 |
| 11/14/2023 | Q3 2023 | -$0.19 | -$0.18 | 0.01 | N/A | $0 |
| 08/10/2023 | Q2 2023 | -$0.41 | -$0.14 | 0.27 | N/A | $0 |
| 05/11/2023 | Q1 2023 | -$0.39 | -$0.60 | -0.21 | N/A | $0 |
| 03/28/2023 | Q4 2022 | -$0.24 | -$0.40 | -0.16 | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$0.05 | -$0.13 | -0.08 | N/A | $0 |
| 08/11/2022 | Q2 2022 | N/A | -$0.36 | N/A | N/A | $0 |
| 05/16/2022 | Q1 2022 | N/A | -$0.12 | N/A | N/A | $0 |
| 03/23/2022 | Q4 2021 | N/A | -$0.06 | N/A | N/A | $0 |
| 11/15/2021 | Q3 2021 | N/A | -$0.01 | N/A | N/A | $0 |
| 08/16/2021 | Q2 2021 | N/A | -$0.07 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
ProKidney Corp Earnings: FAQ's
The conference call for ProKidney Corp's latest earnings report can be listened to online.
The conference call transcript for ProKidney Corp's latest earnings report can be read online.
ProKidney Corp (:PROK) has a recorded annual revenue of $893.00 K.
ProKidney Corp (:PROK) has a recorded net income of $-68,986,000.ProKidney Corp has generated $-0.52 earnings per share over the last four quarters.
ProKidney Corp (:PROK) has a price-to-earnings ratio of -3.31 and price/earnings-to-growth ratio is -0.41.